3rd International Congress and Exhibition
Pharma Qazaqstan & Central Asia
8-9 April 2025, Kazakhstan
+44 207 394 30 90 (London)
8-9 April 2025, Kazakhstan
Pharma Qazaqstan Congress and Exhibition is a unique international platform for leaders of the pharmaceutical industry of Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan and other countries of Central Asia which involves senior executives of investment projects and major pharmaceutical plants, government officials, regulators, technology licensors, developers, manufacturers and suppliers of equipment, engineering and construction companies, technology and service providers. The event is devoted to discussion of major investment projects on construction of production capacities, to efficiency boosting options of pharmaceuticals production.
Head Roche Central Asia, General Manager
Roche Kazakhstan
General Director
Sandoz Kazakhstan
General Director
AMITY International
General Director
Centre for Digital Economy Development
Business Development Director
Medservice Plus
Director of the Representative Office of the Pharmaceutical Plant
CJSC Egis Kazakhstan
Director of the Representative Office of the Pharmaceutical Plant
CJSC Egis Kazakhstan
MODERNIZATION OF THE PLANT FOR THE PRODUCTION OF MEDICAL PREPARATIONS IN ALMATY REGION
Operator/initiator: KFK MEDSERVICE PLYUS
Location: Almaty region
Stage: Documentation and search for contractors
Dates: 4th quarter of 2022 – 4th quarter of 2027
Investment amount: 11,77 million US dollars
The project is aimed at the modernisation of the plant and the production of high-quality products.
LOCALISATION OF MEDICINES PRODUCTION IN THE REPUBLIC OF KAZAKHSTAN
Operator/initiator: Roche Holding
Stage: Planned
Dates: 2023–2024
Investment amount: Not clarified
A project aimed at the localisation of the production of innovative original medicines for the treatment of cancer.
CONSTRUCTION OF PHARMACEUTICAL PLANT IN ALMATY: PRODUCTION OF PREPARATIONS IN THE FORM OF SACHETS AND HIGH-TECH BIOSIMILARS
Operator/initiator: Nobel AFF
Stage: Development of design and estimate documentation, feasibility study
Dates: 2022–2025
Investment amount: 55 million US dollars
The company will contribute to the development of domestic production of original medical preparations and medical devices, increase the export potential of domestic pharmaceutical products, as well as increase scientific and human potential.
CONSTRUCTION OF PLANT FOR THE PRODUCTION OF BIOPHARMACEUTICALS
Operator/initiator: GL Rapha
Stage: Planned
Dates: 2023–2025
Investment amount: 40 million US dollars
It is planned to launch a plant for the contract production of antitumor preparations in Kazakhstan.
EXPANSION OF THE EXISTING PRODUCTION OF MEDICAL PREPARATIONS, AS WELL AS HIP AND KNEE JOINT ENDOPROSTHESES
Operator/initiator: LLP Sultan
Location: Almaty region
Stage: Planned
Investment amount: 18,137 million US dollars
The company has a land plot of 1 hectare and capital buildings with a total area of 5,000 sq. m. (including a building for the production of medical preparations and a workshop for the production of endoprostheses with an area of 2,500 sq. m. and 500 sq. m., respectively). The development of the project will reduce the country’s import dependence on medical preparations and artificial prostheses.
PRODUCTION OF SYRINGES IN ALMATY REGION
Operator/initiator: LLP Dolce
Location: Almaty region, Special Economic Zone Park of Innovative Technologies
Stage: Planned
Investment amount: 5, 731 million US dollars
As part of the project, it is planned to build a syringe production plant with a capacity of 285 million units of products annually. The production will be localised in the special economic zone Park of Innovative Technologies in the Almaty region. The land plot is 5 hectares, the area of industrial premises is 4,000 sq. m.
200+ senior executives of the largest pharmaceutical companies will come together on one platform to discuss the most pressing issues in the industry!
20+ reports with up-to-date information from senior executives of key companies in the industry
30+ largest projects of industry leaders. Demonstration of the development of pharmaceutical plants, plans and projects for the construction of new facilities in Kazakhstan
Presentation of the latest technologies for the construction, modernisation and equipping of pharmaceutical facilities. What are the main stages and tasks in equipping pharmaceutical production facilities?
BIG PHARMA: Contract production and transfer of technologies
Design and construction of pharmaceutical production facilities: compliance with local and international standards, regulatory and normative aspects
TRACK & TRACE. Serialisation and labeling of medical preparations in Kazakhstan and Central Asian countries: progress in introduction of the system and the experience of neighboring countries
SINGLE MARKET OF THE EAEU. Harmoniыation of the single pharmaceutical market of the EAEU, bringing registration dossiers into compliance with the requirements and cooperation of manufacturers within the EAEU
Discussion of wholesale and retail sales of medicines and medical devices: optimisation of logistics, marketing promotion, digitalisation and pricing
30+ hours of business and informal networking! One-on-one meetings, business lunches, coffee breaks, welcome cocktail, and much more
